Here are Wall Street's favorite stocks for 2021
(This story is for CNBC Pro subscribers only.) Juggernaut Amazon, along with comeback plays General Motors and Diamondback Energy, are among the top picks from Wall Street analysts for 2021. After a wild 2020, next year is expected to be a recovery year for the economy as vaccines rollout to combat the Covid pandemic . Analysts expect a mix of tech stocks that worked during 2020 and beaten-down names set to recover to be among the best performers in 2021. CNBC screened for the most-loved stocks on Wall Street heading into 2021 based on the number of analysts with buy ratings on the shares and the average upside to their consensus 12-month price targets. The stocks below have major upside to their 12-month price targets, with some companies expected to see near 40% rallies in the new year. And at least 75% of the analysts who cover the stock say they are a buy. Take a look at the list here. CNBC's list turned out to be a good mix of some beaten down energy and utilities as well as some high growth technology plays. The energy sector is the biggest loser of 2020, shedding more than 35% this year as the Covid-19 pandemic spurred record low oil prices from an evaporation in demand. Wall Street sees some of these stocks rebounding in the new year, like NRG Energy , Diamondback Energy , NiSource and Pioneer Natural Resources . At least 80% of analysts covering the energy names recommend buying the stocks to clients. Most analysts in the energy sector are looking for improvement in the commodity outlook. "We expect the combination of the OPEC+ agreement and reduced activity from U.S. onshore and other non-OPEC countries will result in an improved macro backdrop for 2021 and 2022, with higher prices needed to address our projected undersupplied market in 2022," Stifel told clients. Analysts see NRG Energy rallying more than 32%. Diamondback Energy, NiSource and Pioneer Natural Resources are expected to grow about 30%, 23% and 20% in the new year. Medical device manufacturer Boston Scientific and health insurers Centene and Cigna also made the list. Analysts expect Boston Scientific to gain more than 24%, Centene to grow nearly 40% and Cigna to rally more than 30% next year. "We see a logical story line developing for what we view as a value-oriented investment idea: that CNC's opportunity to drive double-digit annual EPS growth - its reiterated long-term target - stems from an ability to operate more efficiently in the future and to lean more heavily on buybacks," SVBLeerink said of Centene. Equinix , which is the leading global operator of colocation data centers, continues to benefit from the secular trend of IT outsourcing. Companies have increasingly shifted digital workloads from in-house data centers to third-party facilities, especially during the pandemic. Mizuho Securities said the earnings outlook for data center providers will remain strong in 2021, "driven by an expected rebound in enterprise colocation demand, continued strong demand on the cloud front, and stabilization/improvement in hyperscale pricing given current demand/supply fundamentals." "The positive demand/supply picture painted during our Data Center Series makes us believe that 2021 could be another "Beat & Raise" year for the group. We recommend buying the dominant players (DLR, EQIX)," Mizuho's analyst Omotayo Okusanya told clients. Wall Street firms see Equinix rallying more than 20% in 2021. Big Tech Mega-cap technology darlings Amazon and Facebook are also some of Wall Street favorite stocks for 2021. Despite major rallies this year, analysts see the tech giants gaining about 19% apiece next year. Amazon has rallied more than 73% this year as the pandemic caused a lasting shift to e-commerce as millions of Americans shopped for food and household items while avoiding physical stores. Amazon also made a push into the pharmacy space as well as grew its Amazon Web Services cloud business. "We believe the path for growth remains robust for Amazon into FY21 and beyond due to increased penetration of grocery, continued rebound in discretionary products and the large TAM in online pharmacy," Mizuho analyst James Lee said in a note to clients. General Motors, Laboratory Corp. of America, also known as LabCorp., and financial services company Fiserv also made CNBC's list. "Impressive fundamentals, strong leadership, and $30bn available for capital allocation through 2025 make FISV highly attractive," Mizuho Securities said of payments company Fiserv. Morgan Stanley said the market is underestimating the sum of the parts of General Motors, which it sees reaching the $57-per-share level. "We are Overweight based on GM's diversified portfolio, with multiple ways for GM to enhance shareholder value, through: EVs, ICE and Autonomy," Morgan Stanley analyst Adam Jonas told clients. "GM also has leading North American margins, generates strong cash flow, and has a robust balance sheet." On average, analysts expect General Motors to gain 26% in 2021. — With reporting from CNBC's Michael Bloom.

Martin Bureau | AFP | Getty Images